Anastasios Dimou

1.5k citations

67 papers · 800 indexed · h-index 16

Impact in

Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Screening and Detection
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management

Papers in ⓘ

Oncology 43
- Lung Cancer Research Studies 15
- Cancer Immunotherapy and Biomarkers 11
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 5
Internal Medicine 4

Co-authors: Muhammad Wasif Saif (6 shared papers)Kostas Syrigos (4 shared papers)Konstantinos N. Syrigos (7 shared papers)Young Kwang Chae (3 shared papers)Konstantinos Syrigos (4 shared papers)David L. Rimm (7 shared papers)William Tester (2 shared papers)Valsamo Anagnostou (4 shared papers)
Journals: Journal of Clinical Oncology (12 papers)Journal of Thoracic Oncology (5 papers)Cancer (2 papers)Cancer Research (2 papers)JCO Precision Oncology (2 papers)
Partner nations: United States Greece Japan

In The Last Decade

Anastasios Dimou

59 papers receiving 786 citations

Peers

Countries citing papers authored by Anastasios Dimou

Since Specialization

Citations

This map shows the geographic impact of Anastasios Dimou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasios Dimou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasios Dimou more than expected).

Fields of papers citing papers by Anastasios Dimou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastasios Dimou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasios Dimou. The network helps show where Anastasios Dimou may publish in the future.

Co-authors

The 25 scholars most cited alongside Anastasios Dimou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anastasios Dimou Line = papers co-authored together Anastasios Dimou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Disparities in colorectal cancer in African-Americans vs Whites: Before and after diagnosis World Journal of Gastroenterology ·Anastasios Dimou, Kostas Syrigos, Muhammad Wasif Saif	2009	117
2	Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer. Journal of Clinical Oncology ·Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew D. Hellmann, Pradnya D. Patil, Melina E. Marmarelis, Mark M. Awad, Joseph C. Murray, Jessica A. Hellyer, Justin F. Gainor, Anastasios Dimou, Christine M. Bestvina, Catherine A. Shu, Jonathan W. Riess, Collin M. Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Matthias Scheffler, Vassiliki A. Papadimitrakopoulou, John V. Heymach	2019	67
3	Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with oncogene‐driven non–small cell lung cancer Cancer ·Terry L. Ng, Yiwei Liu, Anastasios Dimou, Tejas Patil, Dara L. Aisner, Zhengwei Dong, Tao Jiang, Chunxia Su, Chunyan Wu, Shengxiang Ren, Caicun Zhou, D. Ross Camidge	2018	64
4	Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer Therapeutic Advances in Medical Oncology ·Anastasios Dimou, Konstantinos N. Syrigos, Muhammad Wasif Saif	2012	60
5	MET Gene Copy Number Predicts Worse Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC); A Systematic Review and Meta-Analysis PLoS ONE ·Anastasios Dimou, Lemuel Non, Young Kwang Chae, William Tester, Konstantinos N. Syrigos	2014	46
6	Measurement of Aldehyde Dehydrogenase 1 Expression Defines a Group with Better Prognosis in Patients with Non-Small Cell Lung Cancer American Journal Of Pathology ·Anastasios Dimou, Veronique Neumeister, Seema Agarwal, Valsamo Anagnostou, Konstantinos Syrigos, David L. Rimm	2012	37
7	CT Pulmonary Angiography Utilization in the Emergency Department American Journal of Medical Quality ·Apostolos Perelas, Anastasios Dimou, Augustina Saenz, Ji Hyun Rhee, Krittika Teerapuncharoen, Adam K. Rowden, Glenn Eiger	2014	37
8	Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype Annals of Oncology ·Θεόδωρος Ράμπιας, Eirini Pectasides, Manju L. Prasad, Clarence T. Sasaki, P. Gouveris, Anastasios Dimou, Panteleimon Kountourakis, Christos Perisanidis, Barbara Burtness, Thomas Zaramboukas, David L. Rimm, George Fountzilas, Amanda Psyrri	2013	25
9	Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assay Cancer ·Valsamo Anagnostou, Anastasios Dimou, Taxiarchis Botsis, Elizabeth Killiam, Mark Gustavson, Robert Homer, Daniel J. Boffa, Vassiliki Zolota, Dimitrios Dougenis, L.T. Tanoue, Scott Gettinger, Frank C. Detterbeck, Konstantinos N. Syrigos, Gerold Bepler, David L. Rimm	2011	24
10	Incidental Findings on Computed Tomography Angiography in Patients Evaluated for Pulmonary Embolism Annals of the American Thoracic Society ·Apostolos Perelas, Anastasios Dimou, Augustina Saenz, Ji Hyun Rhee, Krittika Teerapuncharoen, Adam K. Rowden, Glenn Eiger	2015	23
11	Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Cancer American Journal Of Pathology ·Anastasios Dimou, Seema Agarwal, Valsamo Anagnostou, Hollis Viray, Stephen M. Christensen, Bonnie Gould Rothberg, Vassiliki Zolota, Konstantinos Syrigos, David L. Rimm	2011	19
12	Inhibition of Renin Angiotensin Axis May Be Associated with Reduced Risk of Developing Venous Thromboembolism in Patients with Atherosclerotic Disease PLoS ONE ·Young Kwang Chae, Danai Khemasuwan, Anastasios Dimou, S Neagu, Lakshmi Chebrolu, Shikha Gupta, Alejandra Carpio, Jongoh Kim, Jeong H. Yun, Athanasios Smyrlis, Alan L. Friedman, William Tester	2014	19
13	Inhibition of the Hedgehog pathway in lung cancer Lung Cancer ·Anastasios Dimou, A Bamias, Helen Gogas, Konstantinos Syrigos	2019	16
14	The effect of calcium channel blockers on the outcome of acute myeloid leukemia Leukemia & lymphoma ·Young Kwang Chae, Anastasios Dimou, Sherry Pierce, Hagop M. Kantarjian, Michael Andreeff	2014	15
15	Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report Cancer Treatment and Research Communications ·Aakash Desai, Sagar Rakshit, Radhika Bansal, Yash P. Ashara, Ashley Potter, Rami Manochakian, Yanyan Lou, Yujie Zhao, Vinicius Ernani, P. Savvides, Anna Schwecke, Nicole Moffett, Craig Hocum, Konstantinos Leventakos, Alex A. Adjei, Randolph S. Marks, Julian R. Molina, Aaron S. Mansfield, Zongming Chen, Anastasios Dimou	2023	15
16	Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer Clinical Lung Cancer ·Aakash Desai, Caleb J. Smith, Yash P. Ashara, Jacob J. Orme, Saurabh Zanwar, Ashley Potter, Craig Hocum, Jenesse Nicole Moffett, Anna J. Schwecke, Rami Manochakian, Yanyan Lou, Yujie Zhao, Vinicius Ernani, P. Savvides, Julian R. Molina, Anastasios Dimou, Aaron S. Mansfield, Kaushal Parikh, Konstantinos Leventakos	2023	15
17	Neuroendocrine tumors of the pancreas: what's new. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. PubMed ·Anastasios Dimou, Konstantinos N. Syrigos, Muhammad Wasif Saif	2010	15
18	Is there a role for mitomycin C in metastatic colorectal cancer? Expert Opinion on Investigational Drugs ·Anastasios Dimou, Kostas Syrigos, Muhammad Wasif Saif	2010	14
19	Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design Journal of Personalized Medicine ·Anastasios Dimou, Vassiliki A. Papadimitrakopoulou	2014	12
20	Real-World Characteristics and Outcomes of Advanced Non-Small-Cell Lung Cancer Patients with EGFR Exon 19 Deletions or Exon 21 Mutations Future Oncology ·Katherine B. Winfree, Cliff Molife, Patrick Peterson, Yongmei Chen, Carla Visseren‐Grul, Mark S. Leusch, Julie Beyrer, Anastasios Dimou	2021	12

About Anastasios Dimou

Anastasios Dimou is a scholar working on Oncology, Internal Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Otorhinolaryngology, having authored 67 papers that have together received 800 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (15 papers), Lung Cancer Diagnosis and Treatment (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (9 papers), Colorectal Cancer Treatments and Studies (6 papers), Immunotherapy and Immune Responses (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (481 citations), Internal Medicine (57 citations), Pulmonary and Respiratory Medicine (311 citations), Critical Care and Intensive Care Medicine (46 citations) and Cancer Research (115 citations). Anastasios Dimou has collaborated with scholars based in United States, Greece and Japan. Frequent co-authors include Muhammad Wasif Saif, Kostas Syrigos, Konstantinos N. Syrigos, Young Kwang Chae, Konstantinos Syrigos, David L. Rimm, William Tester, Valsamo Anagnostou, Apostolos Perelas and Vassiliki A. Papadimitrakopoulou. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer, Cancer Research and JCO Precision Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact